Intra-Cellular Therapies Inc. buy Royal Bank of Canada
Start price
23.02.24
/
50%
€64.80
Target price
23.02.25
€79.43
Performance (%)
6.48%
Price
26.04.24
€69.00
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 6.48%. This prediction currently runs until 23.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intra-Cellular Therapies Inc. | 1.471% | 1.471% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $86.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€62.50
03.04.24
03.04.24
€79.68
03.04.25
03.04.25
10.40%
26.04.24
26.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€63.60
31.01.24
31.01.24
€79.15
31.01.25
31.01.25
8.49%
26.04.24
26.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€51.40
03.11.23
03.11.23
€70.83
03.11.24
03.11.24
29.38%
26.04.24
26.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.50
04.08.23
04.08.23
€71.56
04.08.24
04.08.24
28.97%
26.04.24
26.04.24
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€44.00
02.03.23
02.03.23
€67.06
02.03.24
02.03.24
50.68%
03.03.24
03.03.24